<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01434017</url>
  </required_header>
  <id_info>
    <org_study_id>CHUV-51-08</org_study_id>
    <nct_id>NCT01434017</nct_id>
  </id_info>
  <brief_title>Comparison of Three Different Prophylactic Treatments of Postoperative Nausea and Vomiting (PONV) in Children</brief_title>
  <official_title>Comparison of Three Different Prophylactic Treatments of PONV in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Vaudois</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Vaudois</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Incidence of postoperative nausea and vomiting (PONV) in children after tonsillectomy with or
      without adenoidectomy may be as high as 75%.

      Several medications may prevent and treat PONV, such as steroids, antidopaminergic drugs and
      serotonin (5-HT3) antagonists. The objective of this study is to compare three prophylactic
      antiemetic treatments:

        -  dexamethasone alone (250 mcg/kg)

        -  dexamethasone (250 mcg/kg) + droperidol (10 mcg/kg)

        -  dexamethasone (250 mcg/kg) + ondansetron (150 mcg/kg).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Tonsillectomy with or without adenoidectomy may be associated with severe postoperative
      nausea and vomiting (PONV). Causes are principally trigeminal nerve stimulation and presence
      of blood in the stomach. Consequences are disagreement, unsatisfactory, delayed discharge,
      and overnight admission in day-cases. More barely, patients may also have suture and
      esophagus rupture, aspiration of gastric contents, dehydration and electrolyte disturbances.

      Several medications may prevent and treat PONV, such as steroids, antidopaminergic drugs and
      serotonin (5-HT3) antagonists. The objective of this study is to compare three prophylactic
      antiemetic treatments:

        -  dexamethasone alone (250 mcg/kg)

        -  dexamethasone (250 mcg/kg) + droperidol (10 mcg/kg)

        -  dexamethasone (250 mcg/kg) + ondansetron (150 mcg/kg).

      The hypothesis is that the combination of dexamethasone and droperidol is as effective as the
      combination of dexamethasone and ondansetron, both of them being more effective than
      dexamethasone alone. Moreover, droperidol is cheaper than ondansetron and may be recommended
      as a first-line treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of PONV after tonsillectomy with or without adenoidectomy</measure>
    <time_frame>48 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of side effects (extrapyramidal syndrome, hemorrhage, somnolence, headaches)</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Postoperative Nausea and Vomiting</condition>
  <arm_group>
    <arm_group_label>Dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive dexamethasone 250 mcg/kg just after induction of anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexamethasone and Droperidol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive dexamethasone 250 mcg/kg + droperidol 10 mcg/kg just after induction of anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexamethasone and Ondansetron</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive dexamethasone 250 mcg/kg + ondansetron 150 mcg/kg just after induction of anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>Patients will receive dexamethasone 250 mcg/kg just after induction of anesthesia.</description>
    <arm_group_label>Dexamethasone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone and droperidol</intervention_name>
    <description>Patients will receive dexamethasone 250 mcg/kg + droperidol 10 mcg/kg just after induction of anesthesia.</description>
    <arm_group_label>Dexamethasone and Droperidol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone and Ondansetron</intervention_name>
    <description>Patients will receive dexamethasone 250 mcg/kg + ondansetron 150 mcg/kg just after induction of anesthesia.</description>
    <arm_group_label>Dexamethasone and Ondansetron</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children aged 2-10 y.

          -  children ASA 1-2

          -  weight &gt; 15 kg

          -  tonsillectomy with or without adenoidectomy

        Exclusion Criteria:

          -  intravenous induction

          -  contraindication to steroids

          -  contraindication to antidopaminergic drugs

          -  contraindication to serotoninergic antagonists

          -  administration of steroids, antidopaminergic drugs, or serotoninergic antagonists in
             the 24 hours before the surgery

          -  refusal of parents

          -  no-french speaking parents
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric Albrecht</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire Vaudois</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Vaudois and University of Lausanne</name>
      <address>
        <city>Lausanne</city>
        <state>Vaud</state>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2011</study_first_submitted>
  <study_first_submitted_qc>September 13, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2011</study_first_posted>
  <last_update_submitted>February 26, 2014</last_update_submitted>
  <last_update_submitted_qc>February 26, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 27, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire Vaudois</investigator_affiliation>
    <investigator_full_name>Eric Albrecht</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>PONV</keyword>
  <keyword>Dexamethasone</keyword>
  <keyword>Droperidol</keyword>
  <keyword>Ondansetron</keyword>
  <keyword>Tonsillectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Ondansetron</mesh_term>
    <mesh_term>Droperidol</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

